TheraRadar
Data updated: May 26, 2026

CLINDAMYCIN PHOSPHATE AND TRETINOIN (clindamycin phosphate)

Dermatology Approved 2015-06-12

CLINDAMYCIN PHOSPHATE AND TRETINOIN is indicated for the treatment of Acne Vulgaris.

Source: FDA Label • Teva
3
Indications
--
Phase 3 Trials
10
Years on Market

Details

Status
Prescription
First Approved
2015-06-12
Routes
TOPICAL
Dosage Forms
GEL

CLINDAMYCIN PHOSPHATE AND TRETINOIN Approval History

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
3 FDA actions from 2015 to 2023
Sep 2023 ORIGINAL
Update
Feb 2022 ORIGINAL
Update
Jun 2015 ORIGINAL
Update

What CLINDAMYCIN PHOSPHATE AND TRETINOIN Treats

1 indications

CLINDAMYCIN PHOSPHATE AND TRETINOIN is approved for 1 conditions since its original approval in 2015. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Acne Vulgaris
Source: FDA Label

CLINDAMYCIN PHOSPHATE AND TRETINOIN Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to CLINDAMYCIN PHOSPHATE AND TRETINOIN

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ACANYA
BENZOYL PEROXIDE
1 shared
BAUSCH
Shared indications:
ACZONE
DAPSONE
1 shared
ALMIRALL
Shared indications:
ADAPALENE AND BENZOYL PEROXIDE
ADAPALENE
1 shared
PADAGIS ISRAEL
Shared indications:
📋

Clinical Trial Registry

3 trials
Trial Sponsor ID Phase Status Title
NCT04469075 19-342 Ph 2 active not recruiting Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
NCT04321070 CLPL 1907 Ph 1 completed Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris
NCT00616330 CBC-302-602-622467 Ph 3 completed Vaginal Infection Study
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CLINDAMYCIN PHOSPHATE AND TRETINOIN FDA Label Details

Indications & Usage

CLINDAMYCIN PHOSPHATE AND TRETINOIN is indicated for the treatment of Acne Vulgaris.

Track CLINDAMYCIN PHOSPHATE AND TRETINOIN with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.